Aortic Regurgitation

Cardiovascular
0
Pipeline Programs
1
Companies
4
Clinical Trials
2 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

JenaValve
JenaValveCA - Irvine
4 programs
JenaValve Pericardial TAVR SystemN/A1 trial
JenaValve Trilogy Heart Valve SystemN/A1 trial
JenaValve Trilogy Heart Valve SystemN/A1 trial
Transcatheter Aortic Valve ReplacementN/A1 trial
Active Trials
NCT02732704Active Not RecruitingEst. Sep 2027
NCT04415047Active Not RecruitingEst. Aug 2028
NCT06594705RecruitingEst. Aug 2027
+1 more trials

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
JenaValveTranscatheter Aortic Valve Replacement
JenaValveJenaValve Trilogy Heart Valve System
JenaValveJenaValve Trilogy Heart Valve System
JenaValveJenaValve Pericardial TAVR System

Clinical Trials (4)

NCT06608823JenaValveTranscatheter Aortic Valve Replacement

ARTIST: Aortic Regurgitation Trial Investigating Surgery Versus Trilogy™

Start: Jun 2025Est. completion: Feb 2036
N/ARecruiting
NCT06594705JenaValveJenaValve Trilogy Heart Valve System

The JenaValve ALIGN-AR LVAD Registry

Start: Dec 2024Est. completion: Aug 2027
N/ARecruiting
NCT04415047JenaValveJenaValve Trilogy Heart Valve System

The JenaValve ALIGN-AR Pivotal Trial

Start: May 2020Est. completion: Aug 2028
N/AActive Not Recruiting
NCT02732704JenaValveJenaValve Pericardial TAVR System

THE ALIGN-AR EFS TRIAL: JenaValve Pericardial TAVR Aortic Regurgitation Study

Start: Apr 2018Est. completion: Sep 2027
N/AActive Not Recruiting

Related Jobs in Cardiovascular

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 actively recruiting trials
1 companies competing in this space